References
- Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Modifications of low-density lipoprotein that increase its atherogenicity. New England Journal of Medicine 1989; 320: 915–924
- Aqel N. M., Ball R. Y., Waldmann H., Mitchinson M. J. Identification of macrophages and smooth muscle cells in human atherosclerosis using monoclonal antibodies. Journal of Pathology 1985; 146: 197–204
- Esterbauer H., Dieber-Rotheneder M., Waeg G., Striegl G., Jurgens G. Biochemical, structural and functional properties of oxidized low-density lipoprotein. Chemical Research in Toxicology 1990; 3: 77–92
- Yla-Herttuäla S., Rosenfeld M. E., Parthasarathy S., Sigal E., Sarkioja T., Witztum J. L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. Journal of Clinical Investigation 1991; 87: 1146–1152
- Heinecke J. W., Rosen H., Suzuki L. A., Chait A. The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein by arterial smooth muscle cells. Journal of Biological Chemistry 1987; 262: 10098–10103
- Sparrow C. P., Olszewski J. Cellular oxidation of low-density lipoprotein is caused by thiol production in media containing transition metals. Journal of Lipid Research 1993; 34: 1219–1228
- Graham A., Wood J. L., O'Leary V. J., Stone D. Human (THP-1) macrophages oxidize LDL by a thiol dependent mechanism. Free Radical Research 1994; 21: 295–308
- Halliwell B., Gutteridge J. M.C. Role of free radicals and catalytic metal ions in human disease. An overview. Methods in Enzymology 1990; 186: 1–85
- Esterbauer H., Striegl G., Puhl H., Rotheneder M. Continuousmonitoringof in vitro oxidation of human low density lipoprotein. Free Radical Research Communications 1989; 6: 67–75
- Gutteridge J. M.C., Rowley D. A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Biochemical Journal 1981; 199: 263–265
- Gutteridge J. M.C. Copper-phenanthroline-induced site specific oxygen radical damage to DNA. Detection of loosely bound trace copper in biological fluids. Biochemical Journal 1984; 218: 983–985
- Evans P. J., Bomford A., Halliwell B. Non-caeruloplasmin copper and ferroxidase activity in mammalian serum. Free Radical Research Communications 1989; 7: 55–62
- Halliwell B., Gutteridge J. M.C. The antioxidants of human extracellular fluids. Archives of Biochemistry and Biophysics 1990; 280: 1–9
- Ehrenwald E., Chisholm G. M., Fox P. L. Intact human ceruloplasmin oxidatively modifies low density lipoprotein. Journal of Clinical Investigation 1994; 93: 1493–1501
- Smith C., Mitchinson M. J., Aruoma O. I., Halliwell B. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions. Biochemical Journal 1992; 286: 901–905
- Lamb C. J. Studies on atherosclerosis. Ph.D. Thesis, University of Reading, UK 1993
- Hoff H. F., O'Neill J. Extracts of human atherosclerotic lesions can modify low density lipoproteins leading to enhanced uptake by macrophages. A therosclerosis 1988; 70: 29–41
- Evans P. J., Halliwell B. Measurement of iron and copper in biological systems: bleomycin and copper-phenanthroline assays. Methods in Enzymology 1994; 233: 82–92
- Foster V., Badimon L., Badimon J. J., Cheesebro J. H. The pathogenesis of coronary artery disease and the acute coronary syndromes. New England Journal of Medicine 1992; 326: 242–249, and326 310-316
- Ross R. Atherosclerosis: a defense mechanism gone awry. American Journal of Pathology 1993; 143: 987–1002
- Rowley D. A., Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds. FEBS Letters 1982; 138: 33–36
- Suarna C., Dean R. T., Stocker R. Does human atherosclerotic plaque provide a pro-oxidant environment?. Proceedings of the 7th Biennial Meeting of the International Society for Free Radical Research. 1995, in press